Skip to main content
logo
Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
16.31
-0.57 (-3.38%)
At close: Apr 28, 2026, 4:00 PM EDT
16.40
+0.09 (0.55%)
After-hours: Apr 28, 2026, 6:29 PM EDT

Amylyx Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
136
Market Cap
1.80B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 202487.37M-293.42M-77.06%
Dec 31, 2023380.79M358.56M1,612.94%
Dec 31, 202222.23M21.95M7,700.00%
Dec 31, 2021285.00K-365.00K-56.15%
Dec 31, 2020650.00K-776.00K-54.42%
Dec 31, 20191.43M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bausch Health Companies10.27B
Perrigo Company4.25B
Phibro Animal Health1.46B
Prestige Consumer Healthcare1.10B
Evotec SE925.65M
ANI Pharmaceuticals883.37M
BioCryst Pharmaceuticals874.84M
Collegium Pharmaceutical780.57M
Revenue Rankings

AMLX News

More News